| United States | Canada | Australia | South Korea | |
---|---|---|---|---|---|
Small molecules | Biologics | ||||
Requirements for exclusivity | be the first ANDA applicant arguing paragraph IV | N/A | N/A | – | (1) the first ANDA that has challenged a patent and obtained a favorable decision; or (2) the first ANDA that has filed a challenge within 14 days of the first challenge and has become the first to obtain a favorable decision (3) filed a challenge within 14 days of the first challenge and become the first to obtain a favourable decision |
Specific measures | 180-day exclusivity | N/A | N/A | N/A | 9-month exclusivity, additional 2-month period is available to compensate for delayed marketing due to the reimbursement process |
A starting point of the measures | the date of the first commercial marketing | N/A | N/A | N/A | the date of the marketing |